Lactobacillus gasseri PA-3 reduces serum uric acid levels in patients with marginal hyperuricemia

Nucleosides Nucleotides Nucleic Acids. 2022;41(4):361-369. doi: 10.1080/15257770.2022.2039702. Epub 2022 Feb 28.

Abstract

Several studies have reported that Lactobacillus gasseri PA-3 reduces the level of serum uric acid (SUA) in patients with hyperuricemia. However, it remains unknown how PA-3 affects uric acid metabolism. In the present study, we examined effects of PA-3-containing yoghurt on uric acid metabolism in patients with marginal hyperuricemia. Sixteen patients with SUA > 357 μmol/L (marginal hyperuricemia) were enrolled. PA-3-containing yoghurt was administered for 8 weeks. Uric acid metabolism was evaluated just before and 8 weeks after the administration and at 4 weeks after the administration ended (post-administration). SUA levels after the administration were significantly lower than that before the administration and remained low at post-administration. Urinary uric acid concentration (Uur) after the administration were significantly lower than that before the administration. However, post-administration Uur levels were comparable to those before the administration. Therefore, PA-3-containing yoghurt significantly reduced the levels of SUA and Uur in patients with marginal hyperuricemia.

Keywords: Lactobacillus gasseri PA-3; serum uric acid; yoghurt.

MeSH terms

  • Humans
  • Hyperuricemia*
  • Lactobacillus gasseri* / metabolism
  • Uric Acid

Substances

  • Uric Acid